Summary
Updated Aug 30, 2026
Stephen T. Zarrilli is Director of GLOBUS MEDICAL INC (GMED). 3 SEC Form 4 filings on record going back to 2025, most recently on 19 August 2026. Most recent open-market trade: sold $2.18M of GMED on 19 August 2026. Lifetime open-market sales: $4.28M.
Recent Transactions
4Every recent SEC Form 4 transaction Stephen T. Zarrilli has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Stephen T. Zarrilli files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David D. Davidar - $4.17M of GMED open-market activity in the last 12 months
- Kelly Huller - $3.44M of GMED open-market activity in the last 12 months
- Kyle Kline - $2.03M of GMED open-market activity in the last 12 months
- Ann D. Rhoads - $1.40M of GMED open-market activity in the last 12 months
- Leslie V. Norwalk - $558K of GMED open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Stephen T. Zarrilli?
Stephen T. Zarrilli is a corporate insider, tracked as Director of GLOBUS MEDICAL INC (GMED). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Stephen T. Zarrilli submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Stephen T. Zarrilli been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($4.28M) across all tracked filings.
Where can I see all of Stephen T. Zarrilli's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Stephen T. Zarrilli and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
